乙酰谷酰胺，CAS 登记号 2490-97-3，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于医药中间体及原料药。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 乙酰谷酰胺 的 CAS 号：2490-97-3，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
N-Acetyl-L-Glutamine · CAS 2490-97-3 · C7H12N2O4. UNII HMS5083L03.
| CAS Registry Number | 2490-97-3 |
|---|---|
| PubChem CID | 25561 |
| Molecular formula | C7H12N2O4 |
| IUPAC name | 2-acetamido-5-amino-5-oxopentanoic acid |
| UNII (FDA) | HMS5083L03 |
| Molecular Weight | 188.18 |
|---|---|
| XLogP3 | -1.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 188.07970687 |
| Monoisotopic Mass | 188.07970687 |
| Topological Polar Surface Area | 109 |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Reported hazard statements | H315 (100%), H319 (100%), H335 (100%) |
|---|
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
4-carbamoyl-2-acetamidobutanoic acid; 5817-09-4; RefChem:520657; 825-602-8; Acetylglutamine; 2-acetamido-5-amino-5-oxopentanoic acid; N(2)-acetylglutamine; N(sup2)-Acetyl-L-glutamine; Acetyl-D-glutamine; Glutamine, N2-acetyl-, L- (8CI); Glutamine, N-acetyl-; alpha-N-Acetyl-L-glutamine;N2-Acetylglutamine; Aceglutamidum [INN-Latin]; N-alpha-Acetyl-L-glutamine; Aceglutamida [INN-Spanish]; NCGC00183120-01
CAS 2490-97-3; molecular formula C7H12N2O4; molecular weight — g/mol.
4-carbamoyl-2-acetamidobutanoic acid, 5817-09-4, RefChem:520657, 825-602-8, Acetylglutamine, 2-acetamido-5-amino-5-oxopentanoic acid.
Hazard statements reported: H315, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.